1. Home
  2. BRX vs CYTK Comparison

BRX vs CYTK Comparison

Compare BRX & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brixmor Property Group Inc.

BRX

Brixmor Property Group Inc.

N/A

Current Price

$27.59

Market Cap

9.1B

Sector

Real Estate

ML Signal

N/A

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$65.62

Market Cap

10.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BRX
CYTK
Founded
2011
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
10.7B
IPO Year
2013
2004

Fundamental Metrics

Financial Performance
Metric
BRX
CYTK
Price
$27.59
$65.62
Analyst Decision
Buy
Buy
Analyst Count
18
22
Target Price
$35.22
★ $109.90
AVG Volume (30 Days)
★ 2.6M
1.5M
Earning Date
10-26-2026
11-04-2026
Dividend Yield
★ 4.46%
N/A
EPS Growth
★ 12.61
N/A
EPS
★ 0.65
N/A
Revenue
★ $1,371,597,000.00
$13,368,000.00
Revenue This Year
$4.03
$70.12
Revenue Next Year
$6.16
$183.63
P/E Ratio
$42.83
★ N/A
Revenue Growth
★ 6.73
N/A
52 Week Low
$24.66
$54.30
52 Week High
$32.86
$88.31

Technical Indicators

Market Signals
Indicator
BRX
CYTK
Relative Strength Index (RSI) 27.37 35.28
Support Level $25.89 $59.05
Resistance Level $31.17 $67.04
Average True Range (ATR) 0.43 2.04
MACD 0.00 -0.10
Stochastic Oscillator 0.82 18.85

Price Performance

Historical Comparison
BRX
CYTK

About BRX Brixmor Property Group Inc.

Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: